Cargando…
Efficient Production of sTNFRII-gAD Fusion Protein in Large Quantity by Use of the Modified CHO-S Cell Expression System
TNFα is one of the initial and important mediators to activate downstream signaling pathways by binding to trimerized TNFα receptors (TNFR), and thus is an ideal drug target for cancer therapy. Taking advantage of intrinsic homotimerization of the globular domain of adiponectin (gAD), we have develo...
Autores principales: | Cai, Qinzhen, Zhao, Ai, Yuting Yin, Ma, Lisha, Jiao, Zhenzhen, Zhi, Huilin, Lai, Shouhua, Cheng, Sha, Yang, Hongmei, Lu, Yinxiang, Siminovitch, Katherine A., Gao, Jimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207793/ https://www.ncbi.nlm.nih.gov/pubmed/25340707 http://dx.doi.org/10.1371/journal.pone.0111229 |
Ejemplares similares
-
sTNFRII-Fc modification protects human UC-MSCs against apoptosis/autophagy induced by TNF-α and enhances their efficacy in alleviating inflammatory arthritis
por: Zhao, Yingjie, et al.
Publicado: (2021) -
Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis
por: Goëb, Vincent, et al.
Publicado: (2005) -
Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma
por: Hu, Minjuan, et al.
Publicado: (2020) -
Ephedrine enhances HIV-1 reactivation from latency through elevating tumor necrosis factor receptor II (TNFRII) expression
por: Panaampon, Jutatip, et al.
Publicado: (2019) -
Etanercept Inhibits B Cell Differentiation by Regulating TNFRII/TRAF2/NF-κB Signaling Pathway in Rheumatoid Arthritis
por: Cai, Xiao-Yu, et al.
Publicado: (2020)